Skip to content
OpenCapital
Get started

UFP Technologies UFPT Net additions (releases) charged to costs and expenses

Net additions (releases) charged to costs and expenses at other companies

Baxter International logo
Baxter InternationalBAX
——
Medline, Inc. logo
Medline, Inc. MDLN
——
Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$154.2M+4.1%
Gross profit$44.4M+5.2%
Operating income$23.4M+1.0%
Net income$17.5M+1.8%
EPS (diluted)$2.24+1.4%

Balance sheet

See full
Cash & equivalents$20.0M+42.4%
Total debt$156.1M-21.4%
Total equity$438.9M+21.7%
Total assets$674.7M+5.0%

Cash flow

See full
Operating cash flow$3.2M-76.8%
CapEx$2.9M+3.1%
Free cash flow$22.5M+151%

Valuation

See full
Market cap$1.88B-3.6%

Profitability

See full
Gross margin28.4%-0.6pp
Operating margin15.2%-0.9pp
Net margin11.3%-0.3pp
FCF margin12.3%+2.0pp

Returns & leverage

See full
Return on equity17.2%-2.2pp
Debt / equity0.4×-0.2×
Current ratio2.9×+0.3×

Where this comes from

Reported directly by UFP Technologies in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: UFP Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about UFP Technologies's net additions (releases) charged to costs and expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is UFP Technologies's net additions (releases) charged to costs and expenses?
UFP Technologies (UFPT) reported net additions (releases) charged to costs and expenses of -$38K in Q1 2026.
How has UFP Technologies's net additions (releases) charged to costs and expenses changed year-over-year?
UFP Technologies's net additions (releases) charged to costs and expenses decreased by 124.2% year-over-year, from $157K to -$38K.
What is the long-term trend for UFP Technologies's net additions (releases) charged to costs and expenses?
Over 2 years (2021 to 2025), UFP Technologies's net additions (releases) charged to costs and expenses has grown at a -58.4% compound annual growth rate (CAGR), from $179K to $31K.